What is the dead-space loss per draw with a 30G needle at 8 mg/mL?

The case in front of me: a 30G needle · 8 mg/mL.

Please show the division. I want to check my own against yours.

I would like the general form as well as the specific number, so I can apply it again.

Is my approach right even if my number is wrong?

More usefully, the single most important fact about dead space is that it is almost entirely in the hub cone, not in the needle, which is why changing needle gauge or length barely changes your losses.

At 5 mg/mL that is 15 to 25 µg lost per draw on the insulin syringe and 175 to 500 µg on the luer-lock — which over ten draws is the difference between losing a rounding error and losing half a milligram.

Mechanically, the needle lumen volume is under a microlitre in a typical fine-gauge configuration, so the needle is not the problem.

The switch nearly doubles your vial, which is better than most other optimisations combined.

This is arithmetic, so let us do the arithmetic and see where the losses actually are.

The luer cone of the syringe plus the needle's own plastic hub accounts for the vast majority of the dead space.

In practice, be sceptical of anything advertised as low dead space that retains a conventional plunger tip: if you can look into the fitting with the plunger fully forward and see an open conical void, that void is your dead space.

Published inter-laboratory comparisons of dead-space measurements on identical syringes show good agreement, suggesting the numbers are reliable.

If cost matters, this is the first thing to change, not the last.

In practice, dead space is irreducible with a high-dead-space syringe, which is why the hardware matters more than any technique.

Low-dead-space syringe designs either have the needle bonded directly to the barrel — a fixed-needle syringe, which is the cheapest route — or add a moulded projection on the plunger tip that fills the luer cone.

The underlying point is that dead space quantified: a fixed-needle insulin syringe holds roughly 3 to 5 µL in the hub and needle after the plunger bottoms out. A luer-lock syringe with a detachable needle holds 35 to 100 µL depending on the hub design.

I would not underestimate the dead-space cost when calculating your true cost per dose.

Buy the right syringe — a fixed-needle insulin syringe is cheap and solves the problem.

At 100 µL draws the dead-space penalty with a luer-lock is 84 per cent per draw — the cost is genuinely catastrophic.

The complete rule: fix the syringe architecture first, and then the reconstitution volume becomes a free choice you can make on stability grounds rather than on economics.

The limitation is that even with perfect technique, some loss is irreducible unless you switch to a low-dead-space syringe.

The switch nearly doubles your vial, which is better than most other optimisations combined.

edited 13 Sept 2025 by h_pergande — clarified the distinction between purity and content

Changing syringe architecture changes everything, while changing needle gauge changes almost nothing.

Configuration B — 0.5 mL fixed-needle U-100 insulin syringe, dead space 2 µL: volume removed per draw = 100 + 2 = 102 µL.

Syringe residual volume has been measured properly, mainly in the infection-control literature, with a median residual of about 84 µL for a conventional 1 mL syringe with a detachable needle and roughly 2 µL for a fixed-needle low-dead-space design.

Worth noting: draw size matters enormously — the smaller your draws, the more the syringe architecture matters.

If cost matters, this is the first thing to change, not the last.